AD/PD 2023 | Facilitation of dementia diagnosis across the world

Panos Alexopoulos, MD, PhD, MA, University of Patras, Patras, Greece & Global Brain Health Institute, Dublin, Ireland, explains the importance of considering non-cognitive symptoms (such as neuropsychiatric) in the diagnosis and management of dementia, which can often be overlooked. The assessment of dementia is expensive and time-consuming. In many countries, there is a lack of geriatricians and neurologists to aid in the diagnosis, and dementia is only diagnosed by the GP. Therefore, diagnostics such as the Geriatric Depression Scale could be great tools to enable rapid dementia screening globally, independent of the facilities available or the economic situation. This interview took place at the AD/PD™ 2023 congress in Gothenburg, Sweden.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.